1. Home
  2. AIMD vs PLUR Comparison

AIMD vs PLUR Comparison

Compare AIMD & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ainos Inc.

AIMD

Ainos Inc.

SELL

Current Price

$1.24

Market Cap

10.6M

Sector

Health Care

ML Signal

SELL

Logo Pluri Inc.

PLUR

Pluri Inc.

SELL

Current Price

$0.91

Market Cap

12.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AIMD
PLUR
Founded
1984
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
12.5M
IPO Year
2008
2026

Fundamental Metrics

Financial Performance
Metric
AIMD
PLUR
Price
$1.24
$0.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 4.0M
62.3K
Earning Date
11-16-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 31.46
EPS
N/A
★ N/A
Revenue
$124,157.00
★ $1,016,000.00
Revenue This Year
N/A
$902.46
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 498.95
N/A
52 Week Low
$0.43
$0.85
52 Week High
$3.88
$3.94

Technical Indicators

Market Signals
Indicator
AIMD
PLUR
Relative Strength Index (RSI) 60.79 39.73
Support Level $0.50 $0.88
Resistance Level $1.75 $1.85
Average True Range (ATR) 0.30 0.13
MACD 0.08 -0.03
Stochastic Oscillator 51.47 10.61

Price Performance

Historical Comparison
AIMD
PLUR

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: